Collegium Pharmaceutical (COLL) Non Operating Income (2014 - 2017)
Collegium Pharmaceutical (COLL) recorded quarterly Non Operating Income of $180000.0 in Q4 2017, up 7.78% quarter-over-quarter from $167000.0 in Q3 2017, and up 800.0% on a YoY basis from $20000.0 in Q4 2016.
Collegium Pharmaceutical (COLL) Non Operating Income (2014 - 2017) Analysis & Trends
Collegium Pharmaceutical's Non Operating Income history runs 4 years deep, the most recent figure standing at $180000.0 for Q4 2017.
- In Q4 2017, Non Operating Income rose 800.0% year-over-year to $180000.0; the TTM figure through Dec 2017 stood at $582000.0 (up 719.15% YoY), while the FY2017 annual figure was $582000.0, up 719.15% from the prior year.
- Non Operating Income was $180000.0 for Q4 2017 at Collegium Pharmaceutical, up from $167000.0 in the prior quarter.
- In the past five years, Non Operating Income ranged from a high of $180000.0 in Q4 2017 to a low of -$142000.0 in Q4 2014.
- Historically, Non Operating Income has averaged -$7000.0 across 4 years, with a median of -$38000.0 in 2014.
- The sharpest annual moves came in 2015 and 2017: Non Operating Income sank 241.38% in 2015, then surged 8450.0% in 2017.
- A 4-year view of Non Operating Income shows it stood at -$142000.0 in 2014, then surged by 37.32% to -$89000.0 in 2015, then jumped by 122.47% to $20000.0 in 2016, then soared by 800.0% to $180000.0 in 2017.
- The last three Non Operating Income figures came in at $180000.0 (Q4 2017), $167000.0 (Q3 2017), and $137000.0 (Q2 2017), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Op. Inc. (Qtr) |
|---|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn | -216.00 Mn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn | 20.00 Mn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn | -7.50 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn | -504,111.66 |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn | 53.40 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn | - |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn | -13.65 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn | -23.23 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn | 5.71 Mn |
| 10 | Collegium Pharmaceutical | 1.10 Bn | 813.71 Mn | 117.25 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2017 | 180,000.00 |
| Sep 30, 2017 | 167,000.00 |
| Jun 30, 2017 | 137,000.00 |
| Mar 31, 2017 | 98,000.00 |
| Dec 31, 2016 | 20,000.00 |
| Sep 30, 2016 | -2,000.00 |
| Jun 30, 2016 | -46,000.00 |
| Mar 31, 2016 | -66,000.00 |
| Dec 31, 2015 | -89,000.00 |
| Sep 30, 2015 | -97,000.00 |
| Jun 30, 2015 | -99,000.00 |
| Mar 31, 2015 | -63,000.00 |
| Dec 31, 2014 | -142,000.00 |
| Sep 30, 2014 | -51,000.00 |
| Jun 30, 2014 | -29,000.00 |
| Mar 31, 2014 | -30,000.00 |